Synapse - Diane Reidy

Search Within

Diane Lauren Reidy

Results (298)

A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin

Meeting Abstract

Raj, N.; Chan, J.; Dasari, A.; Capanu, M.; Tang, L.; Reidy-Lagunes, D.
Pancreas (2017)

Fulltext@MSK | Save

Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology: Well differentiated versus poorly differentiated

Journal Article

Raj, N.; Valentino, E.; Capanu, M.; Tang, L. H.; Basturk, O.; Untch, B. R.; Allen, P. J.; Klimstra, D. S.; Reidy-Lagunes, D.
Pancreas (2017)

Fulltext@MSK | Save

Clinical and genetic determinants of ovarian metastases from colorectal cancer

Journal Article

Ganesh, K.; Shah, R. H.; Vakiani, E.; Nash, G. M.; Skottowe, H. P.; Yaeger, R.; Cercek, A.; Lincoln, A.; Tran, C.; Segal, N. H.; more...
Cancer (2017)

Fulltext@MSK | Save

Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*

Journal Article

Huguet, F.; Hajj, C.; Winston, C. B.; Shi, W.; Zhang, Z.; Wu, A. J.; O’Reilly, E. M.; Reidy, D. L.; Allen, P.; Goodman, K. A.
Acta Oncologica (2017)

Fulltext@MSK | Save

Gene signature associated with upregulation of the Wnt/β-catenin signaling pathway predicts tumor response to transarterial embolization

Journal Article

Ziv, E.; Yarmohammadi, H.; Boas, F. E.; Petre, E. N.; Brown, K. T.; Solomon, S. B.; Solit, D.; Reidy, D.; Erinjeri, J. P.
Journal of Vascular and Interventional Radiology (2017)

Fulltext@MSK | Save

Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients

Meeting Abstract

Segal, N. H.; Kemeny, N. E.; Cercek, A.; Reidy, D. L.; Raasch, P. J.; Warren, P.; Hrabovsky, A. E.; Campbell, N.; Shia, J.; Goodman, K. A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Safety and efficacy of lanreotide depot/autogel (LAN) in patients with lung NETs: The randomized, double-blind, placebo (PBO)-controlled phase III SPINET study

Meeting Abstract

Reidy, D. L.; Kulke, M. H.; Wolin, E. M.; Singh, S.; Ferone, D.; Mirakhur, B.; Massien, C.; Houchard, A.; Caplin, M. E.; Baudin, E.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT

Meeting Abstract

Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Somatic tumor profiling of DNA mismatch repair deficient (MMR-D) colorectal cancers (CRC)

Meeting Abstract

Ganesh, K.; Middha, S.; Hechtman, J. F.; Ashraf, A.; Tran, C.; Villano, D.; Yaeger, R. D.; Segal, N. H.; Cercek, A.; Varghese, A. M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Design of a phase 3, international, prospective, randomized, double-blind, placebo (PBO) controlled study assessing efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in patients with well-differentiated, advanced typical and atypical lung NETs

Meeting Abstract

Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Mirakhur, B.; Massien, C.; Caplin, M.; Baudin, E.
Neuroendocrinology (2016)

Fulltext@MSK | Save